Refine by
Locations
- Africa
- Algeria
- Angola
- Benin
- Botswana
- Burkina Faso
- Burundi
- Cameroon
- Cape Verde
- Central African Republic
- Chad
- Comoros
- Congo
- Congo, Democratic Republic Of The
- Djibouti
- Egypt
- Equatorial Guinea
- Eritrea
- Ethiopia
- Gabon
- Gambia
- Ghana
- Guinea
- Guinea-Bissau
- Ivory Coast
- Kenya
- Lesotho
- Liberia
- Libya
- Madagascar
- Malawi
- Mali
- Mauritania
- Mauritius
- Morocco
- Mozambique
- Namibia
- Niger
- Nigeria
- Rwanda
- Senegal
- Seychelles
- Sierra Leone
- Somalia
- South Africa
- St. Helena
- Sudan
- Swaziland
- SãO Tomé & PríNcipe
- Tanzania
- Togo
- Tunisia
- Uganda
- Zaire
- Zambia
- Zimbabwe
Dust Mite Allergy Equipment & Supplies In Africa
4 equipment items found
Manufactured by:Citeq Biologics based inGroningen, NETHERLANDS
When in patients the specific Der p 1-antibodies are detected it shows high levels of specific Der p 1-antibodies which indicates that the patient has house dust mite allergy. ...
Manufactured by:Hangzhou Hengyi Textile Co., Ltd based inHangzhou, CHINA
People may develop an allergy to house dust mite. This means they are sensitive to the excrements of these creatures. The health problems faced by allergy patients are mainly irritations of the mucus membranes: allergic rhinitis and asthma. It is a known fact that asthma patients who are allergic to house mites ...
Manufactured by:ICB Pharma based inJaworzno, POLAND
Innovative solution for neutralisation of house dust allergens. ALLERGOFF® spray supports the treatment of allergies caused by allergens present in house dust, such as house dust mites allergens, storage dust mites allergen, pet allergens, spores of fungi and ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Enoximone is an inotropic vasodilating agent and a selective and orally active phosphodiesterase III (PDE3) inhibitor with an IC50 of 5.9 μM. Enoximone induces vasodilatation and increases intracellular levels of cAMP by inhibiting cGMP-inhibited PDE. Enoximone also exhibits PDE4 inhibitory effect with an IC50 of 21.1 μM for myocardial PDE4A. Enoximone has the potential for congestive heart ...